Clinical trial
The Role of Alpha Melanocyte Stimulating Hormone in Ocular Disease
NCT03451578 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Alpha Melanocyte Stimulating Hormone in Ocular Disease
- Lead sponsor
- Duke University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 6, 2018
- Completion date
- October 19, 2021
- Enrollment
- 54 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
advanced dry macular degeneration